We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NBSE market cap is 1.45M. The company's latest EPS is USD -9.0572 and P/E is -0.05.
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.93M | -8.36M | -7.72M | -4.6M | -3.69M |
| Net Income | -9.92M | -8.49M | -7.63M | -4.37M | -3.45M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.23M | 0 | 0 | 0 | 0 |
| Operating Income | -13.9M | -26.34M | -17.33M | -26.79M | -33.73M |
| Net Income | -13.24M | -26.96M | -17.39M | -25.41M | -33.78M |
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.81M | 40M | 32.69M | 25.58M | 22.33M |
| Total Liabilities | 10.64M | 9.69M | 9.5M | 7.36M | 11.09M |
| Total Equity | 38.16M | 30.31M | 23.19M | 18.22M | 11.25M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.63M | 12.53M | 34.44M | 64.17M | 32.69M |
| Total Liabilities | 725k | 2.5M | 3.15M | 10.1M | 9.5M |
| Total Equity | 10.9M | 10.03M | 31.3M | 54.07M | 23.19M |
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.46M | -22.37M | -29.01M | -5.69M | -7.09M |
| Investing | -272k | -443k | -472k | -50k | -4k |
| Financing | -202k | -229k | -256k | -29k | 4.46M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.49M | -2.85M | -10.71M | -18.87M | -29.01M |
| Investing | 528k | -685k | -717k | -2.56M | -472k |
| Financing | -86k | 13.6M | 33.11M | 42.34M | -256k |
| Market Cap | 1.45M |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.07 |
| Price to Book Ratio | 0.07 |
| Dividend Yield | - |
| Shares Outstanding | 3.73M |
| Average Volume (1 week) | 23.71k |
| Average Volume (1 Month) | 50.24k |
| 52 Week Change | -86.58% |
| 52 Week High | 4.80 |
| 52 Week Low | 0.39 |
| Spread (Intraday) | 0.62 (62.4%) |
| Company Name | NeuBase Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.neubasetherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
